Iwai Yoshiyasu, Yamanaka Kazuhiro, Honda Yuji, Matsusaka Yasuhiro
Department of Neurosurgery, Osaka City General Hospital, Osaka, Japan.
Neurol Med Chir (Tokyo). 2004 Mar;44(3):112-6; discussion 117. doi: 10.2176/nmc.44.112.
Gamma knife radiosurgery (GKS) was used to treat seven patients with pituitary metastases between November 1994 and February 2003. The diagnoses were based on magnetic resonance imaging and clinical symptoms in six patients and by previous surgery in one patient. The cancer originated in the lung in five patients, and in the breast in two patients. The tumor volume was 0.2 to 9.6 cm3 (mean 4.0 cm3). The marginal dose was 10 to 14 Gy (mean 11.9 Gy) because of the close proximity to the optic apparatus. The maximum radiation dose to the optic apparatus was 8 to 10 Gy (mean 9.5 Gy). The survival period after GKS was 0.3 to 42 months (mean 11.5 months). Five patients died of systemic disease, and one patient died of unknown causes 10 days after GKS. Tumor growth was controlled in five of the six patients (83%) followed up after GKS. Tumor regrowth was seen 18 months after GKS in one patient. The clinical symptoms improved in five of the six patients (83%) followed up. GKS is effective and useful for the primary treatment of pituitary metastases with limited survival and less invasiveness compared to conventional radiation therapy.
1994年11月至2003年2月期间,7例垂体转移瘤患者接受了伽玛刀放射外科治疗(GKS)。6例患者的诊断基于磁共振成像和临床症状,1例患者基于既往手术。5例患者的癌症原发于肺,2例原发于乳腺。肿瘤体积为0.2至9.6立方厘米(平均4.0立方厘米)。由于靠近视器,边缘剂量为10至14 Gy(平均11.9 Gy)。对视器的最大辐射剂量为8至10 Gy(平均9.5 Gy)。GKS后的生存期为0.3至42个月(平均11.5个月)。5例患者死于全身性疾病,1例患者在GKS后10天死于不明原因。GKS后随访的6例患者中有5例(83%)肿瘤生长得到控制。1例患者在GKS后18个月出现肿瘤复发。随访的6例患者中有5例(83%)临床症状改善。与传统放射治疗相比GKS对生存期有限的垂体转移瘤的初始治疗有效且具有较小的侵袭性。